11月 2025
- 首頁
- MacroGenics
11月 2025MacroGenics的市場佔有率分析
Nasdaq: MGNX), , today announced that the Company's management will. Oct 31, 2023. MacroGenics Announces Date of Third Quarter 2023 Financial Results Conference Call.
MacroGenics(包含公司地區)
查看更多網站流量與參與度資訊- macrogenics.com
MacroGenics截至 11月 2025 的總收入為 100M - 200M
MacroGenics 熱門網域產生的總收入
MacroGenics 熱門網域 3 年內的總收入
MacroGenics 熱門網域的總收入
MacroGenics的熱門網域總造訪量
了解MacroGenics市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
MacroGenics的熱門網域平均造訪時長
分析MacroGenics參與度指標。
過去 3 個月平均造訪時長
子公司細目
MacroGenics的熱門網域平均頁面瀏覽量
了解MacroGenics如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自MacroGenics
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞MacroGenics, Inc. attended event Goldman Sachs 46th Annual Global Healthcare Conference 2025 on Nov 13th '25.MacroGenics, Inc., a biopharmaceutical company specializing in antibody-based cancer therapies, announced that its President and CEO, Eric Risser, will participate in a fireside chat at the Stifel 2025 Healthcare Conference on November 13, 2025, at 4:00 pm ET in New York City.
11月 6, 2025閱讀更多
新聞MacroGenics, Inc. attends event H.C. Wainwright 27th Annual Global Investment Conference.ROCKVILLE, MD, Sept. 02, 2025 (GLOBE NEWSWIRE) - MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that MacroGenics' President & Chief Executive Officer, Eric Risser, will present at the H.C. Wainwright 27th Annual Global Investment Conference on Monday, September 8, 2025, at 11:30am ET in New York, NY.
9月 2, 2025閱讀更多
新聞MacroGenics, Inc. promotes Eric Risser to president and CEO.MacroGenics promotes Eric Risser to president and CEO.
8月 14, 2025閱讀更多
查看所有MacroGenics信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。